Market by Treatment Type, End-user, and Country | Forecast 2019-2028
Triton’s report estimates that the North American periodontal market is projected to grow at a CAGR of 7.63% in the evaluated years 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries
considered for analysis in this market are:
• United States
• Canada
In North America, the
rising patient awareness, relatively higher disposable income, and surging
demand for cosmetic dental care, are factors majorly contributing to the growth
of the periodontal market. Moreover, the rising dental care facilities are
another factor that is projected to positively impact the studied market’s
growth in the future. In the United States, the prevalence of periodontal
disease and tooth decay are considered massive threats to the dental health of
the people.
Also, gum disease can
be associated with other diseases such as diabetes and heart disease. This has
made the maintenance of healthy teeth and gums a compulsive norm across the
country. Although, despite a high occurrence of diseases like periodontitis,
the number of people seeking treatment is less. Hence, it increases the need
for dental care facilities, further enhancing the market’s growth in the United
States.
Similarly, periodontal
diseases are considered a widespread dental problem in Canada. As mentioned by the
Canadian Dental Association, a significant amount of the population is affected
by serious periodontal diseases. This has further led to an increase in dental
care spending, over the years, in private and public sectors. Moreover, this
has also increased the demand for dental services across the country, and is
expected to further surge over the projected phase.
Furthermore, as stated by
the Canadian Academy of Periodontology, diabetic patients are more vulnerable
to periodontal diseases, requiring more periodontal care than non-diabetic
patients. The institution is also creating awareness among citizens to prevent
periodontal diseases. Such research activities and rise in dental care
expenditure, are expected to boost the Canadian periodontal market on a growth
path.
Oral Science offers
products that are utilized in maintaining oral hygiene and treating oral
diseases. This specialty dental company functions in various dental divisions,
including tooth sensitivity, high-risk caries, periodontitis, and whitening.
Oral Science links its inventory based on the needs of the patient, education,
clinical tips, and awareness in society. The company has a wide clientele base,
with its headquarter located in Canada.
1. NORTH
AMERICA PERIODONTAL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF NEW ENTRY
2.2.3. THREAT
OF SUBSTITUTE PRODUCTS
2.2.4. BARGAINING
POWER OF BUYERS
2.2.5. BARGAINING
POWER OF SUPPLIERS
2.2.6. THREAT
OF COMPETITIVE RIVALRY
2.3. IMPACT
OF COVID-19 ON PERIODONTAL MARKET
2.4. REGULATORY
OUTLOOK
2.5. KEY
INSIGHTS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. MARKET
DRIVERS
2.8.1. SURGING
AGING POPULATION
2.8.2. RISING
EDENTULOUS POPULATION
2.9. MARKET
RESTRAINTS
2.9.1. EXPENSIVE
PERIODONTAL SURGERY
2.9.2. LACK
OF PROPER DIAGNOSIS IN TREATMENT
2.10. MARKET OPPORTUNITIES
2.10.1. TECHNOLOGICAL DEVELOPMENTS
2.10.2. GROWING DENTAL AND MEDICAL TOURISM INDUSTRY
2.11. MARKET CHALLENGES
2.11.1. REIMBURSEMENT ISSUES
2.11.2. LACK OF CONCERN TOWARDS DENTAL CARE
3. NORTH
AMERICA PERIODONTAL MARKET OUTLOOK - BY TREATMENT TYPE
3.1. NON-SURGICAL
TREATMENT
3.1.1. THERAPY
3.1.1.1. LOCAL
ANTIBIOTICS
3.1.1.1.1. ARESTIN
3.1.1.1.2. OTHER LOCAL ANTIBIOTICS
3.1.1.2. SYSTEMIC
ANTIBIOTICS
3.1.1.2.1. MINOCYCLINE
3.1.1.2.2. DOXYCYCLINE
3.1.1.2.3. OTHER SYSTEMIC ANTIBIOTICS
3.1.2. LASER
TREATMENT
3.2. SURGICAL
DEVICES
3.2.1. DENTAL
BONE IMPLANTS
3.2.1.1. ENDOSTEAL
3.2.1.2. SUBPERIOSTEAL
3.2.2. DENTAL
BONE GRAFTING
3.2.2.1. XENOGRAFT
3.2.2.2. ALLOGRAFT
3.2.2.3. OTHER
DENTAL BONE GRAFTING
4. NORTH
AMERICA PERIODONTAL MARKET OUTLOOK - BY END-USER
4.1. DENTAL
CLINICS AND LABORATORIES
4.2. HOSPITALS
4.3. DENTAL
RESEARCH INSTITUTES
4.4. OTHER
END-USERS
5. NORTH
AMERICA PERIODONTAL MARKET - REGIONAL OUTLOOK
5.1. COUNTRY
OUTLOOK
5.1.1. THE
UNITED STATES
5.1.2. CANADA
6. COMPANY
PROFILES
6.1. ULTRADENT
PRODUCTS INC
6.2. ZIMMER
BIOMET INC
6.3. ORAL
SCIENCE
6.4. BAUSCH
HEALTH COMPANIES INC
6.5. STRAUMANN
6.6. BIOLASE
6.7. DENMAT
HOLDINGS LLC
6.8. 3M
COMPANY
6.9. YOUNG
INNOVATIONS
6.10. DENTSPLY SIRONA
6.11. DEXCEL PHARMA
6.12. HENRY SCHEIN INC (BIO HORIZONS IMPLANT SYSTEMS
INC)
6.13. APTERYX IMAGING
6.14. MEDTRONIC PLC
6.15. DANAHER CORPORATION
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
PERIODONTAL MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: NORTH AMERICA
PERIODONTAL MARKET, BY TREATMENT TYPE, 2019-2028 (IN $ MILLION)
TABLE 3: NORTH AMERICA
NON-SURGICAL TREATMENT MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA
LOCAL ANTIBIOTICS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA
SYSTEMIC ANTIBIOTICS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA
SURGICAL DEVICES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
DENTAL BONE IMPLANTS MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA
DENTAL BONE GRAFTING MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
PERIODONTAL MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
PERIODONTAL MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA
PERIODONTAL MARKET 2019-2028 (IN $ MILLION)
FIGURE 2: NORTH AMERICA
PERIODONTAL MARKET, BY NON-SURGICAL TREATMENT, 2019-2028 (IN $ MILLION)
FIGURE 3: NORTH AMERICA
NON-SURGICAL TREATMENT MARKET, BY THERAPY, 2019-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA
THERAPY MARKET, BY LOCAL ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA
LOCAL ANTIBIOTICS MARKET, BY ARESTIN, 2019-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
LOCAL ANTIBIOTICS MARKET, BY OTHER LOCAL ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
THERAPY MARKET, BY SYSTEMIC ANTIBIOTICS, 2019-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
SYSTEMIC ANTIBIOTICS MARKET, BY MINOCYCLINE, 2019-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
SYSTEMIC ANTIBIOTICS MARKET, BY DOXYCYCLINE, 2019-2028 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA SYSTEMIC ANTIBIOTICS MARKET, BY OTHER SYSTEMIC ANTIBIOTICS, 2019-2028
(IN $ MILLION)
FIGURE 11: NORTH
AMERICA NON-SURGICAL TREATMENT MARKET, BY LASER TREATMENT, 2019-2028 (IN $
MILLION)
FIGURE 12: NORTH
AMERICA PERIODONTAL MARKET, BY SURGICAL DEVICES, 2019-2028 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA SURGICAL DEVICES MARKET, BY DENTAL BONE IMPLANTS, 2019-2028 (IN $
MILLION)
FIGURE 14: NORTH
AMERICA DENTAL BONE IMPLANTS MARKET, BY ENDOSTEAL, 2019-2028 (IN $ MILLION)
FIGURE 15: NORTH
AMERICA DENTAL BONE IMPLANTS MARKET, BY SUBPERIOSTEAL, 2019-2028 (IN $ MILLION)
FIGURE 16: NORTH
AMERICA SURGICAL DEVICES MARKET, BY DENTAL BONE GRAFTING, 2019-2028 (IN $
MILLION)
FIGURE 17: NORTH
AMERICA DENTAL BONE GRAFTING MARKET, BY XENOGRAFT, 2019-2028 (IN $ MILLION)
FIGURE 18: NORTH
AMERICA DENTAL BONE GRAFTING MARKET, BY ALLOGRAFT, 2019-2028 (IN $ MILLION)
FIGURE 19: NORTH
AMERICA DENTAL BONE GRAFTING MARKET, BY OTHER DENTAL BONE GRAFTING, 2019-2028
(IN $ MILLION)
FIGURE 20: NORTH
AMERICA PERIODONTAL MARKET, BY DENTAL CLINICS AND LABORATORIES, 2019-2028 (IN $
MILLION)
FIGURE 21: NORTH AMERICA
PERIODONTAL MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
FIGURE 22: NORTH
AMERICA PERIODONTAL MARKET, BY DENTAL RESEARCH INSTITUTES, 2019-2028 (IN $
MILLION)
FIGURE 23: NORTH
AMERICA PERIODONTAL MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
FIGURE 24: THE UNITED
STATES PERIODONTAL MARKET 2019-2028 (IN $ MILLION)
FIGURE 25: CANADA
PERIODONTAL MARKET, 2019-2028 (IN $ MILLION)